US–Dutch–Chinese biotech Harbour BioMed (HKEX: 02142) has extended its partnership with British pharma major AstraZeneca (LSE ...

The Russian drugmaker Akselpharm has successfully defended its patent for osimertinib the active ingredient of UK pharma ...

US biotech major Biogen and privately-held Dayra Therapeutics have announced a research collaboration to discover and develop ...

Germany’s STADA Arzneimittel has received marketing authorizations from the European Commission (EC) for its Kefdensis and ...

Privately-held Italian drugmaker Angelini Pharma has breached the Code of Practice for the Association of the British ...

The Danish government’s push to let citizens buy medicines from countries outside the EU is drawing sharp criticism from Lif, ...

Shares Danish pharma major Novo Nordisk were down 9.5% at 275.80 kroner today, after it announced disappointing top-line ...

US pharma major Johnson & Johnson (NYSE: JNJ) has halted its Phase IIb AuTonomy study after posdinemab failed to achieve a ...

Switzerland is becoming the benchmark for American drug prices, warns the trade body Interpharma. A new US model links ...

The US Food and Drug Administration (FDA) has approved Padcev (enfortumab vedotin-ejfv), a nectin-4 directed antibody-drug ...

The global cell therapy market is valued at $5.5 billion in 2025 and is projected to reach $12.2 billion by 2030, reflecting strong investment in manufacturing scale, allogeneic platforms, and ...

Swiss biosimilars and generics company Sandoz today announced the European launch of Afqlir (aflibercept), a 2 mg vial kit ...